Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Times Utah.
Press releases published on August 20, 2025
Phathom Pharmaceuticals Clarifies That There Is No Reduction in Lead Shareholder’s Ownership Following Administrative Change to 13D Filing
GlobeNewswire
·
August 20, 2025
FLORHAM PARK, N.J., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), today clarified that a Schedule 13D filing by Frazier Life Sciences, which is expected to be filed later today, August 20, will include administrative …
genXtraits Inc. and Mendel Biotechnology, Inc. enter collaboration
GlobeNewswire
·
August 20, 2025
ALAMEDA, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- San Francisco Bay Area-based crop biotechnology firms genXtraits, Inc. (genXtraits) and Mendel Biotechnology, Inc. (Mendel) have announced that they have entered a collaboration to develop new crop traits. …
Inspire Medical Systems, Inc. to Present at the Wells Fargo 2025 Healthcare Conference
GlobeNewswire
·
August 20, 2025
MINNEAPOLIS, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive …
AI in Remote Patient Monitoring (RPM) Market to Reach USD 8,438.5 Million by 2030 | MarketsandMarkets™
GlobeNewswire
·
August 20, 2025
Delray Beach, FL, Aug. 20, 2025 (GLOBE NEWSWIRE) -- The global AI in remote patient monitoring market, valued at US$1551.8 million in 2023, stood at US$1,967.7 million in 2024 and is projected to advance at a resilient CAGR of 27.5% from 2024 to 2030, …
Iterum Therapeutics launches ORLYNVAH™, the first and only oral penem antibiotic in the U.S.
GlobeNewswire
·
August 20, 2025
DUBLIN and CHICAGO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and …
BBOT to Participate in Upcoming September Investor Healthcare Conferences
GlobeNewswire
·
August 20, 2025
SOUTH SAN FRANCISCO, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today announced that members of its leadership …
Beyond Air Signs New International LungFit PH® Distribution Agreements, Most Notably in Japan
GlobeNewswire
·
August 20, 2025
GARDEN CITY, N.Y., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve patient …
Best Day Brewing Adds to Core Brew Lineup with Galaxy Ripple IPA
GlobeNewswire
·
August 20, 2025
SAUSALITO, Calif , Aug. 20, 2025 (GLOBE NEWSWIRE) -- Best Day Brewing, America's fastest-growing non-alcoholic craft beer brand, is excited to announce its fan-favorite Imperial IPA style brew, Galaxy Ripple, is officially joining the brand’s flagship NA …
OneMedNet Adds 2.7M Annual Cardiovascular Studies, Expanding Network
GlobeNewswire
·
August 20, 2025
MINNEAPOLIS, Aug. 20, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq:ONMD) (“OneMedNet” or the “Company”), a leader in AI-powered Real-World Data (RWD), announced the addition of 85 cardiovascular centers and data sources, expanding its …
BrainsWay Acquires Minority-Stake in Axis Integrated Mental Health
GlobeNewswire
·
August 20, 2025
BURLINGTON, Mass. and JERUSALEM, Aug. 20, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ …
TerrAscend Announces Renewal and Replenishment of $10 Million Share Repurchase Program
GlobeNewswire
·
August 20, 2025
TORONTO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis company, today announced that its Board of Directors has authorized the Company to renew and replenish …
Anavex Life Sciences Announces New Publication in Medical Journal: Blarcamesine Prevented Cognitive Impairment in Animal Model of Alzheimer’s Disease
GlobeNewswire
·
August 20, 2025
Pre-Treatment with blarcamesine entirely prevented Abeta-induced cognitive decline Confirmed significant biomarker-response in hippocampus NEW YORK, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a …
Rezolute Appoints Seasoned Commercial Executive Sunil Karnawat as Chief Commercial Officer
GlobeNewswire
·
August 20, 2025
REDWOOD CITY, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism (HI), today announced the appointment of Sunil …
MediWound to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
August 20, 2025
YAVNE, Israel, August 20, 2025 -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced that Ofer Gonen, Chief Executive Officer, will participate in a fireside chat, hosted by …
Cytokinetics Names Jim Daly to Board of Directors
GlobeNewswire
·
August 20, 2025
SOUTH SAN FRANCISCO, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the appointment of James M. Daly to its Board of Directors effective August 19, 2025. Mr. Daly brings over 30 years of global …
Genome Editing Market to Grow at 16.9% CAGR Through 2030
GlobeNewswire
·
August 20, 2025
Boston, Aug. 20, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the “Genome Editing: Technologies and Global Markets” is projected to grow from $10.8 billion in 2025 to $23.7 billion by the end of 2030, at a compound annual …
First PRIZM Study Participant Enrolled in Tisento Therapeutics’ Open-Label Extension Study in MELAS
GlobeNewswire
·
August 20, 2025
CAMBRIDGE, Mass., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Tisento Therapeutics today announced that the first participant has enrolled in the company’s open-label extension study in MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like …
Iantrek Raises $42 Million Series C to Launch AlloFlo™ Uveo, a Breakthrough Interventional Glaucoma Therapy
GlobeNewswire
·
August 20, 2025
WHITE PLAINS, N.Y., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Iantrek, Inc., a pioneer in bio-interventional ophthalmic surgery (BIOS), today announced the close of a $42 million Series C financing round, which will fund the U.S. commercial launch of AlloFlo™ Uveo …
I-Mab Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 20, 2025
Positive givastomig Phase 1b dose escalation data in combination with immunochemotherapy in patients with 1L gastric cancers presented at ESMO GI 2025 showing 83% ORR at doses selected for ongoing expansion study Topline data from planned dose expansion …
Eton Pharmaceuticals to Participate at 2025 Wells Fargo Healthcare Conference
GlobeNewswire
·
August 20, 2025
DEER PARK, Ill., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that members …